CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

2.90USD
17 Sep 2014
Price Change (% chg)

$-0.02 (-0.68%)
Prev Close
$2.92
Open
$2.92
Day's High
$2.96
Day's Low
$2.89
Volume
71,729
Avg. Vol
282,718
52-wk High
$8.34
52-wk Low
$2.01

CYTR.OQ

Chart for CYTR.OQ

About

CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology. The Company's oncology pipeline includes three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib. INNO-206 is the Company's tumor-targeted doxorubicin conjugate. On May 13, 2011,... (more)

Overall

Beta: 1.82
Market Cap (Mil.): $161.68
Shares Outstanding (Mil.): 55.75
Dividend: --
Yield (%): --

Financials

  CYTR.OQ Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -1.20 -- --
ROI: -93.09 -2.42 17.39
ROE: -93.09 -7.11 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks